Cargando…
Plasmodium vivax Controlled Human Malaria Infection – Progress and Prospects
Modern controlled human malaria infection (CHMI) clinical trials have almost entirely focussed on Plasmodium falciparum, providing a highly informative means to investigate host–pathogen interactions as well as assess potential new prophylactic and therapeutic interventions. However, in recent years...
Autores principales: | Payne, Ruth O., Griffin, Paul M., McCarthy, James S., Draper, Simon J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270241/ https://www.ncbi.nlm.nih.gov/pubmed/27956060 http://dx.doi.org/10.1016/j.pt.2016.11.001 |
Ejemplares similares
-
Haematological response in experimental human Plasmodium falciparum and Plasmodium vivax malaria
por: Woolley, Stephen D., et al.
Publicado: (2021) -
The challenges of Plasmodium vivax human malaria infection models for vaccine development
por: Roobsoong, Wanlapa, et al.
Publicado: (2023) -
Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study
por: Townell, Nicola, et al.
Publicado: (2012) -
Plasmodium vivax Malaria
por: Kochar, Dhanpat K., et al.
Publicado: (2005) -
Epidemiology of Plasmodium vivax Malaria Infection in Nepal
por: Rijal, Komal Raj, et al.
Publicado: (2018)